Gibson Christopher
SEC Form 4 insider trading activity
Gibson Christopher has filed 22 SEC Form 4 filings (51 transaction rows) across 2 companies, including RXRX, PACB, with disclosures dating back to 2025. 19 of those filings fall inside the rolling window. Most recent filing: Jun 5, 2026.
On the most recent filing, Gibson Christopher is listed as Director at RECURSION PHARMACEUTICALS, INC. Inside the rolling window, Gibson Christopher reported no open-market purchases and 15 open-market sales totaling $2.8M in RXRX. The largest disclosed transaction in the window is a sale of 100,000 RXRX shares on Oct 23, 2025, worth $570K.
Companies traded
Other insiders at RXRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.8M
reported sales (SEC code S)
Companies
2
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| RXRX | Director | Sale | 40,000 | $145K | Jun 5 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $123K | May 27 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $135K | May 8 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $144K | Apr 24 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $124K | Apr 8 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $130K | Mar 25 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $138K | Feb 19 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $165K | Feb 6 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $179K | Jan 22 | SEC ↗ | |
| RXRX | Director | Sale | 40,000 | $170K | Jan 7 | SEC ↗ | |
| RXRX | Chief Executive Officer | Sale | 40,000 | $180K | Dec 19 | SEC ↗ | |
| RXRX | Chief Executive Officer | Sale | 40,000 | $185K | Dec 5 | SEC ↗ | |
| RXRX | Chief Executive Officer | Sale | 40,000 | $166K | Nov 19 | SEC ↗ | |
| RXRX | Chief Executive Officer | Sale | 40,000 | $208K | Nov 6 | SEC ↗ | |
| RXRX | Chief Executive Officer | Sale | 100,000 | $570K | Oct 24 | SEC ↗ |
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Gibson Christopher made?
Gibson Christopher has filed 22 SEC Form 4 filings (51 transaction rows) across 2 companies, including RXRX, PACB since 2025.
Which companies does Gibson Christopher trade?
Gibson Christopher has filed SEC Form 4 disclosures for 2 companies, including RXRX, PACB.
When was Gibson Christopher's most recent SEC Form 4 filing?
Gibson Christopher's most recent SEC Form 4 filing on Tracefour is dated Jun 5, 2026.
What is Gibson Christopher's total buy and sell value in the current window?
Inside the rolling retention window, Gibson Christopher bought $0 and sold $2.8M based on SEC Form 4 filings.
What was Gibson Christopher's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 100,000 RXRX shares on 2025-10-23, worth $570K, per SEC Form 4 filings.